Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

Decommissioning serial numbers is emerging as a critical best practice in the pharmaceutical industry, enhancing DSCSA compliance and supply chain integrity. By formally retiring products from the supply chain using standardized EPCIS data, manufacturers can prevent fraud, support audits, and improve traceability. This proactive step strengthens patient safety and protects against the re-entry of counterfeit or expired drugs.

• Read more about Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

How Marketers Are Using Data To Elevate Creator Content

HOW DO YOU BUILD SMARTER CREATOR CAMPAIGNS? When it comes to creator marketing, today’s biggest wins come from an intentional blend of creativity and precision. Moving beyond chasing likes and shares, brands can accomplish much more by tapping into data to drive smarter decisions at every stage: who to partner with, how to scale content, when to boost it, and what actually worked.

• Read more about How Marketers Are Using Data To Elevate Creator Content

The Specialty Pharmacy Squeeze

Specialty pharmacies are under growing financial pressure due to high drug costs, delayed reimbursements, and limited access to support programs like 340B. This cash-flow strain threatens patient access—especially in underserved areas—as some pharmacies are forced to close or exit the market. Addressing the crisis requires faster payments, expanded program access, and reform of pharmacy benefit manager practices to ensure the sustainability of specialty care.

• Read more about The Specialty Pharmacy Squeeze

Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

Medication waste in hospitals stems from outdated inventory practices and poor visibility. By adopting real-time data and automation, health systems can reduce waste, improve care readiness, and enhance operational efficiency.

• Read more about Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

2025 Holiday Forecast Report

The 2025 holiday season will be defined by purposeful spending. Consumers will not shy away from the season but their priorities, budgets and expectations will look different in 2025. Economic pressures, wellness goals, and nonlinear shopping journeys will reshape how and when decisions are made. In Inmar’s 2025 Holiday Commerce Report, learn how: 

• Read more about 2025 Holiday Forecast Report

Pharmacies, Meet Your Most Underrated Asset

Reverse distribution is pharmacy’s secret weapon—cutting costs, easing compliance burdens, and fueling smarter planning. In this VerifiedRx episode, Inmar and Vizient experts unpack how this often-overlooked process boosts efficiency, supports sustainability, and keeps supply chains strong. A vital listen for health system leaders and pharmacy pros ready to level up logistics strategy.

• Read more about Pharmacies, Meet Your Most Underrated Asset

Why Hospitals are Racing to Secure Essential Medications

Persistent drug shortages are pushing hospitals to rethink supply chains, adopt new technologies, and advocate for policies that ensure critical medication access.

• Read more about Why Hospitals are Racing to Secure Essential Medications

Celebrating Inmar’s 2025 Top Women in Grocery Honorees

We’re excited to announce that three of Inmar’s very own — Laura Arnett, Haley Boyle, and Ranjana Choudhry — have been named winners of Progressive Grocer’s 2025 Top Women in Grocery (TWIG) awards.

• Read more about Celebrating Inmar’s 2025 Top Women in Grocery Honorees

How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges

Pharmaceutical recalls are complex and high-risk. This article breaks down the top challenges manufacturers face and offers proactive strategies to manage recalls efficiently and protect patient safety.

• Read more about How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges